Chargement en cours...
Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
BACKGROUND: Scleroderma is a connective tissue disease causing fibrosis and commonly affects the skin and internal organs such as the GI tract, lungs, kidney and heart. Most people with scleroderma also have Raynaud's phenomenon (RP). One of the possible treatment options for RP in scleroderma...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
1998
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032891/ https://ncbi.nlm.nih.gov/pubmed/10796396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000954 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|